Table 5 Laboratory results of the entire cohort at a patient’s first clinic visit (only untreated patients)
From: Risk stratification of patients with familial hypercholesterolemia in a multi-ethnic cohort
Risk factor | With CVD | Without CVD | P-value |
|---|---|---|---|
N = 74 | N = 221 | ||
Total cholesterol (mmol/L) | 8.2(1.8) | 9.1(2.1) | <0.001 |
Mean (SD) | |||
HDL cholesterol (mmol/L) | 1.2(0.3) | 1.4(0.4) | 0.001 |
Mean (SD) | |||
LDL-cholesterol (mmol/L) | 6.1(1.8) | 7.0(1.9) | <0.001 |
Mean (SD) | |||
Triglycerides (mmol/L) | 1.7(0.9) | 1.7(1.2) | 0.968 |
Mean (SD) | |||
TC/HDL | 7.5(3.5) | 7.3(2.8) | 0.684 |
Mean (SD) | |||
Lp (a) (mg/L)* | 331.5 | 278.8 | 0.480 |
Median (IQR) | (111.2,691.6) | (102.6,569.7) | |
Fasting blood sugar (mmol/L) | 5.4(0.6) | 5.1(0.5) | 0.001 |
Mean (SD) | |||
Lipid lowering therapy (%) | 0.0 | 0.0 | NA |